| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 955 | 15.905 | 39.683 | 109.816 | 94.502 | 139.074 | 205.813 | 224.557 | 198.790 |
| Total Income - EUR | - | 955 | 15.905 | 39.683 | 109.816 | 94.502 | 139.074 | 205.813 | 405.562 | 198.951 |
| Total Expenses - EUR | - | 873 | 9.382 | 18.247 | 33.706 | 27.064 | 22.527 | 66.859 | 216.905 | 80.725 |
| Gross Profit/Loss - EUR | - | 82 | 6.523 | 21.436 | 76.110 | 67.438 | 116.547 | 138.954 | 188.657 | 118.227 |
| Net Profit/Loss - EUR | - | 63 | 6.364 | 21.039 | 75.012 | 66.564 | 115.184 | 137.205 | 185.210 | 112.975 |
| Employees | - | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Neurologie Şi Psihiatrie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 64 | 763 | 136.919 | 135.589 | 133.686 | 135.361 | 657.912 | 515.724 | 572.452 |
| Current Assets | - | 876 | 8.609 | 14.758 | 34.338 | 13.154 | 17.254 | 33.841 | 219.689 | 35.175 |
| Inventories | - | 0 | 0 | 1.440 | 0 | 0 | 2 | 0 | 3 | 0 |
| Receivables | - | 508 | 2.120 | 6.286 | 24.021 | 8.119 | 12.745 | 22.263 | 17.618 | 23.067 |
| Cash | - | 369 | 6.489 | 7.033 | 10.317 | 5.034 | 4.507 | 11.578 | 202.068 | 12.108 |
| Shareholders Funds | - | 108 | 6.470 | 21.090 | 75.062 | 95.097 | 135.163 | 220.350 | 349.539 | 297.197 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 833 | 3.015 | 130.918 | 95.228 | 52.101 | 17.727 | 471.747 | 386.258 | 308.621 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurologie Şi Psihiatrie Srl